Shares of Aurobindo Pharma fell 1% to Rs 497.85 in intra-day trade on Tuesday for the fifth consecutive day after the company’s half-subsidiary Aurolife received...
The approval has been received from US Food & Drug Administration (USFDA) for Aurobindo Pharma to manufacture Medroxyprogesterone Acetate Injectable Suspension USP with 150 mg/mL,...
Nifty Pharma stocks were in fast lane on Wednesday tracking all market clues. The performance in pharma stocks comes after when the RBI Governor Shaktikanta...
Indian equity markets continued their record-breaking run, extending their winning streak for the seventh straight day, ending at another record high. The S&P BSE Sensex...
Aurobindo Pharma said the US health regulator has decided that the inspection classification of company’s injectable formulation manufacturing facility at Hyderabad is voluntary action...
One of India’s leading drug-maker, Aurobindo Pharma has obtained the final approval from the US health regulator for its Azithromycin oral suspension used for the...